دورية أكاديمية
Intensified cytarabine dose during consolidation in adult AML patients under 65 years is not associated with survival benefit: real-world data from the German SAL-AML registry
العنوان: | Intensified cytarabine dose during consolidation in adult AML patients under 65 years is not associated with survival benefit: real-world data from the German SAL-AML registry |
---|---|
المؤلفون: | Hanoun, MaherAff1, IDs00432022043569_cor1, Ruhnke, Leo, Kramer, Michael, Hanoun, Christine, Schäfer-Eckart, Kerstin, Steffen, Björn, Sauer, Tim, Krause, Stefan W., Schliemann, Christoph, Mikesch, Jan-Henrik, Kaufmann, Martin, Hänel, Mathias, Jost, Edgar, Brümmendorf, Tim H., Fransecky, Lars, Kraus, Sabrina, Einsele, Hermann, Niemann, Dirk, Neubauer, Andreas, Kullmer, Johannes, Seggewiss-Bernhard, Ruth, Görner, Martin, Held, Gerhard, Kaiser, Ulrich, Scholl, Sebastian, Hochhaus, Andreas, Reinhardt, H. Christian, Platzbecker, Uwe, Baldus, Claudia D., Müller-Tidow, Carsten, Bornhäuser, MartinAff2, Aff22, Serve, Hubert, Röllig, Christoph |
المصدر: | Journal of Cancer Research and Clinical Oncology. 149(8):4611-4621 |
قاعدة البيانات: | Springer Nature Journals |
تدمد: | 01715216 14321335 |
---|---|
DOI: | 10.1007/s00432-022-04356-9 |